jRCT2071220081
已完成
不适用
ONO-4685-04:ONO-4685 Phase 1 study Single intravenous continuous infusion and subcutaneous administration study in Japanese healthy adult male subjects
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Ono Pharmaceutical Co.,LTD
- 入组人数
- 72
- 主要终点
- -
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Japanese healthy adult male subjects
- •Age at the time of informed consent: 18 to 45
- •BMI (at screening): 18.5 kg/m2 to less than 25.0 kg/m2
排除标准
- •Subjects who are on a treatment for or with a history of respiratory, cardiovascular, psychiatric, neurologic, gastrointestinal, immunologic, hepatic, renal, hematopoietic or endocrine and/or other disease.
- •Subjects with current or with a history of severe allergy to drugs or foods
- •Subjects with current or with a history of drug or alcohol abuse
结局指标
主要结局
-
Safety, Pharmacokinetics
相似试验
招募中
1 期
ONO-4685-04: ONO-4685 Phase 1 studyAuto immune diseaseJPRN-jRCT2071220081Masahiro Osawa72
进行中（未招募）
1 期
ONO-4578-04:ONO-4578 Phase 1 Studymetastatic pancreatic cancerJPRN-jRCT2031200286Hirashima Yoshinori60
招募中
1 期
ONO-4685-05:A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SRelapsed or refractory T-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphomaJPRN-jRCT2011230051Osawa Masahiro108
进行中（未招募）
1 期
ONO-4578-05:ONO-4578 Phase 1 Studyon-small cell lung cancerJPRN-jRCT2031200346Osawa Masahiro40
进行中（未招募）
1 期
ONO-4578-03:ONO-4578 Phase 1 StudyJPRN-jRCT2051200096Hirashima Yoshinori30